ACD PHARMACEUTICALS AS: årsregnskap 2017 vs 2016
Grew 60% on revenue, returned to profit
approved 2018-06-21; registry 2018-07-18; journal 2018 710298
Summary
What changed
Comparing Årsregnskap 2017 with 2016 for ACD PHARMACEUTICALS AS. Revenue 7.56m NOK → 12.06m NOK (+59.5%). Net result -306.1k NOK → +480.5k NOK. Equity 6.71m NOK → 2.20m NOK.
On the constructive side: revenue rose; turned profitable; cash rose. Pressures included: equity eroded.
Also worth watching: paid-in equity reduced. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 7.56m NOK to 12.06m NOK (+59.5% YoY). Calculated
-
↑
Turned profitable
Net result flipped from a loss of 306.1k NOK to a profit of 480.5k NOK. Calculated
-
↑
Cash rose
Bank deposits 149.9k NOK → 173.6k NOK (+15.9% YoY). Calculated
-
↑
Payroll decreased
Salary cost 3.60m NOK → 2.68m NOK (48% → 22% of revenue). Calculated
What deteriorated
-
↓
Equity eroded
Book equity 6.71m NOK → 2.20m NOK (equity ratio 65.1% → 16.5%). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 3.65m NOK → 300.0k NOK — check capital reduction, conversion, or reclassification. Interpretation